Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
NPHCNutra Pharma Corp
| Figure | NPHCNutra Pharma CorpFY2025 · Dec |
|---|---|
| Revenue | $257.61K |
| Revenue, yoy | +4.6% |
| Net income | $2.05M |
| Net income, yoy | −59.2% |
| Net margin | -794.8% |
| Free cash flow | $1.19M |
| FCF margin | -461.9% |
| EPS, diluted | $0.00 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed